Vesalius Biocapital offers venture capital
to young European innovative life science companies
ProFibrix leverages its expertise in fibrinogen technology to develop and market innovative products for the hemostasis and regenerative medicine markets.
Therapeutics & Drug Delivery
The Netherlands
Investing phase